IL-10 RNA tranfected autograft macrophage cell therapy (University of Heidelberg)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIL-10 RNA tranfected autograft macrophage cell therapy (University of Heidelberg)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionInterleukin 10 receptor agonists
TargetsInterleukin 10 receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Heidelberg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Heidelberg
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A